微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.9% | -3.46% | 7.93% | 127/141 | 52.4% | 佰仁医疗科技 | 88.71% | 行业排名> |
| 2026-03-31 | 14.73% | -3.55% | 24% | 123/141 | 52.37% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-12-31 | 11.88% | -33.65% | -17.24% | 126/141 | 51.9% | 佰仁医疗科技 | 89.18% | 行业排名> |
| 2025-09-30 | 14.35% | -9.38% | -12.84% | 123/141 | 52.23% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-06-30 | 16.47% | 7.8% | 7.82% | 124/141 | 52.48% | 佰仁医疗科技 | 88.54% | 行业排名> |
| 2025-03-31 | 15.27% | -14.19% | -14.69% | 123/141 | 52.13% | 佰仁医疗科技 | 85.72% | 行业排名> |
| 2024-12-31 | 17.9% | 8.07% | 13.02% | 123/141 | 53.08% | 佰仁医疗科技 | 88.34% | 行业排名> |
| 2024-09-30 | 15.84% | -16.15% | 3.69% | 122/141 | 53.87% | 佰仁医疗科技 | 88.56% | 行业排名> |
| 2024-06-30 | 15.28% | -21.86% | -14.17% | 125/141 | 53.95% | 佰仁医疗科技 | 89.27% | 行业排名> |
| 2024-03-31 | 17.8% | -7.98% | 7.44% | 118/141 | 53.88% | 佰仁医疗科技 | 89.28% | 行业排名> |
| 2023-12-31 | 16.57% | -4.76% | -12.3% | 122/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 18.89% | -0.16% | -3.38% | 114/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 19.55% | 14.47% | 1.07% | 118/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 19.34% | 36.02% | 11.21% | 116/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 17.39% | -4.55% | -8.07% | 124/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 18.92% | -38.62% | 10.78% | 114/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 17.08% | -46.7% | 20.09% | 121/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 14.22% | -58.54% | -21.96% | 111/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 18.22% | -40.53% | -40.88% | 125/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 30.82% | -3.17% | -3.8% | 99/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 32.04% | -3.25% | -6.59% | 107/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 34.3% | 35.96% | 11.95% | 88/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 30.64% | 42.21% | -3.75% | 120/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 31.83% | 33.42% | -3.88% | 84/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 33.12% | 31.06% | 31.26% | 101/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 25.23% | 3.42% | 17.11% | 72/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 21.55% | -12.61% | -9.7% | 115/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 23.86% | -6.11% | -5.58% | 63/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 25.27% | -1.95% | 3.58% | 71/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 24.4% | -10.61% | -1.05% | 52/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 24.65% | 4.64% | -2.99% | 108/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 25.41% | 10.24% | -1.39% | 50/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 25.77% | 3.81% | -5.57% | 56/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 27.29% | 14.43% | 15.84% | 47/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 23.56% | -3.47% | 2.21% | 102/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 23.05% | -11.91% | -7.15% | 47/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 24.83% | -15.89% | 4.08% | 56/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 23.85% | -3.44% | -2.27% | 43/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 24.41% | -6.87% | -6.72% | 77/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 26.17% | -8.53% | -11.35% | 38/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 29.52% | 31.29% | 19.49% | 46/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 24.7% | -21.35% | -5.75% | 33/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |